DaVita HealthCare Partners Inc. 3rd Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
DaVita (DVA) PT Trimmed to $90 at Piper Jaffray Post Q3; Maintains 'Overweight'
November 4, 2015 8:47 AM ESTPiper Jaffray analyst Kevin Ellich lowered his price target on DaVita (NYSE: DVA) to $90.00 (from $92.00) but maintained an Overweight rating.
Ellich commented, "While Q3 results beat Street estimates and HCP's operating income improved, DVA faces a number of potential headwinds that could reduce HCP's operating... More
DaVita (DVA) Tops Q3 EPS by 3c, Offers Outlook
November 3, 2015 4:40 PM ESTDaVita (NYSE: DVA) reported Q3 EPS of $1.00, $0.03 better than the analyst estimate of $0.97. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.46 billion.
Outlook
We are updating our consolidated operating income for 2015 to now be in the range of $1.870 billion to $1.915 billion.
Our... More
